Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
-23.8K
-
Total reported value, excl. options
-
$83.8M
-
Value change
-
-$965K
-
Put/Call ratio
-
0.38
-
Number of buys
-
22
-
Number of sells
-
-25
-
Price
-
$6.06
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2020
64 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q3 2020.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 27.5M outstanding shares and own 50.38% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Avoro Capital Advisors LLC (1.67M shares), Sonic Fund II, L.P. (1.63M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.12M shares), 683 Capital Management, LLC (1.11M shares), BlackRock Inc. (1.08M shares), Solas Capital Management, LLC (800K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (431K shares), STATE STREET CORP (328K shares), and Russell Investments Group, Ltd. (218K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.